Dr. Barry A. Hendin By Dr. Barry A. Hendin MSAA’s Chief Medical Officer Q: What is COVID-19 and how might I be affected because of my MS? A: COVID-19 is […]
Read News ArticleAuthor: Hoff Communications
Up Front: MSAA Adapts while Reaching a Milestone
Gina Ross Murdoch By Gina Ross Murdoch MSAA President and CEO The current coronavirus (COVID-19) pandemic has turned life upside-down for virtually everyone in the United States and many throughout […]
Read News ArticleResearch News
FDA Approves Zeposia® for Relapsing Forms of MS On March 26, 2020, Bristol Myers Squibb announced that the United States Food and Drug Administration (FDA) approved Zeposia® (ozanimod) for the treatment […]
Read News ArticleThoughts about Giving: Little Tiny Things Add Up
By Erich Fasnacht, Vice President of Development Fundraising profiles by Kaitlyn Gallagher EVERYTHING that the Multiple Sclerosis Association of America does is made possible by tiny acts of kindness that […]
Read News ArticleThe Motivator: Winter/Spring 2020 – Download PDF
– or – No thank you – download file only
Read News ArticleProgram Notes
Stay Updated on COVID-19 and MS by Watching Our Ongoing Webinar Series Recognizing the importance of providing the multiple sclerosis community with the most accurate and up-to-date information possible on […]
Read News ArticleWhat You Need to Know About COVID-19 and MS – Program 2
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc Recorded on April 13, 2020, this second installment of our ongoing webinar series provides the latest news and updates at the […]
Read News Article
What You Need to Know About COVID-19 and MS – Program 1
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc Presented on March 30, 2020 with the most updated information available at the time of broadcast, MSAA encourages you to watch […]
Read News Article